Medicare Enrolled
Dr. Gary Olson, M.D.
Cardiovascular Disease · Dalton, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Olson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Olson
Dr. Gary Olson is a cardiovascular disease specialist in Dalton, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Olson performed 3,593 Medicare services across 1,978 unique beneficiaries.
Between the years covered by Open Payments, Dr. Olson received a total of $13,212 from 44 pharmaceutical and/or device companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Olson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in GA
$13,212 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,593
Medicare services
Top 20% in GA for cardiovascular disease
1,978
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~180 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
481 | $84 | $221 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
442 | $6 | $20 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
424 | $4 | $14 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
398 | $7 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
287 | $8 | $15 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
227 | $9 | $59 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
217 | $130 | $643 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
155 | $13 | $43 |
| Sulfur hexafluoride lipid microspheres injection Injection of sulfur hexafluoride lipid microspheres measured per milliliter. |
130 | $14 | $20 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
129 | $25 | $125 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
119 | $4 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
84 | $60 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
69 | $115 | $292 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
66 | $16 | $70 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
66 | $11 | $60 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
65 | $58 | $200 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
54 | $22 | $99 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
48 | $18 | $79 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $37 | $146 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $90 | $225 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
26 | $26 | $212 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $101 | $277 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
18 | $14 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
9.1% medium
79.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,212
Total received (2018-2024)
Avg $1,887/year across 7 years
Top 17% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
730
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,200 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$612
2023
$2,303
2022
$2,661
2021
$2,290
2020
$1,111
2019
$2,272
2018
$1,964
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$161
E.R. Squibb & Sons, L.L.C.
$142
Novartis Pharmaceuticals Corporation
$104
Abbott Laboratories
$28
Amgen Inc.
$24
Novo Nordisk Inc
$23
Actelion Pharmaceuticals US, Inc.
$22
Inari Medical, Inc.
$21
Kiniksa Pharmaceuticals International, plc
$19
Siemens Medical Solutions USA, Inc.
$19
AstraZeneca Pharmaceuticals LP
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$16
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$2,935
Novartis Pharmaceuticals Corporation
$1,845
Amgen Inc.
$1,412
AstraZeneca Pharmaceuticals LP
$1,364
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$772
PFIZER INC.
$659
E.R. Squibb & Sons, L.L.C.
$620
Boston Scientific Corporation
$520
Medtronic Vascular, Inc.
$463
Novo Nordisk Inc
$405
Merck Sharp & Dohme LLC
$260
Boehringer Ingelheim Pharmaceuticals, Inc.
$256
SANOFI-AVENTIS U.S. LLC
$161
Amarin Pharma Inc.
$125
Esperion Therapeutics, Inc.
$120
Abbott Laboratories
$114
Kowa Pharmaceuticals America, Inc.
$92
PORTOLA PHARMACEUTICALS, INC.
$92
Medtronic, Inc.
$76
Actelion Pharmaceuticals US, Inc.
$76
ATRICURE, INC.
$73
BOSTON SCIENTIFIC CORPORATION
$72
Bayer HealthCare Pharmaceuticals Inc.
$54
CARDIVA MEDICAL, INC.
$54
Gilead Sciences, Inc.
$54
Cardiovascular Systems Inc.
$53
iRhythm Technologies, Inc.
$49
Lexicon Pharmaceuticals, Inc.
$47
United Therapeutics Corporation
$46
Siemens Medical Solutions USA, Inc.
$44
Inari Medical, Inc.
$35
ShockWave Medical, Inc
$30
Edwards Lifesciences Corporation
$28
ARBOR PHARMACEUTICALS, INC.
$25
Astellas Pharma US Inc
$21
PORTOLA PHARMACEUTICALS, LLC
$21
MEDICOMP INC
$20
Kiniksa Pharmaceuticals, Ltd.
$20
Kiniksa Pharmaceuticals International, plc
$19
Allergan Inc.
$19
Merck Sharp & Dohme Corporation
$17
Daiichi Sankyo Inc.
$17
Molnlycke Health Care US, LLC
$16
Chiesi USA, Inc.
$12
Top 3 companies account for 46.9% of all-time payments
Associated products mentioned in payments ›
ACIST RXi NAVVUS · AMPLATZER Occluders · ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · AZURE XT DR MRI SURESCAN · Arcalyst · Artis icono floor · Azure · BEVYXXA · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · Cardiva VASCADE 6/7F VCS · Cardiva VASCADE MVP VVCS 6-12F · CareLink · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DxTerity · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · GALLANT · INJECTAFER · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · Mepilex Border Post-Op Ag · NEXLETOL · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · TELEPATCH CARDIAC MONITOR · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
25
Per 100K population
24.2
County median income
$64,262
Nearest hospital
HAMILTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Olson is a clinical cardiology specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement in the top 17% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Olson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Olson performed 481 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Olson receive payments from pharmaceutical companies?
Yes. Dr. Olson received a total of $13,212 from 44 companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Olson's costs compare to other cardiologists in Dalton?
Dr. Olson's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Olson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Dalton
Browse cardiologists in Dalton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in GA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in GA
Which GA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology